The trademark application BELIRTY was filed by UniQure IP B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on July 1, 2020, and it was registered by office on October 9, 2020 without any oppositions.
The application was filed in Dutch (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical products
Pharmaceutical preparations and vaccines for use in gene therapy and cell therapy: biological preparations for use in medical and clinical gene therapy and cell therapy
Clinical medical reagents for use in gene therapy, gene diagnosis and gene testing.